Wordt geladen...
In Silico Repositioning of Cannabigerol as a Novel Inhibitor of the Enoyl Acyl Carrier Protein (ACP) Reductase (InhA)
Cannabigerol (CBG) and cannabichromene (CBC) are non-psychoactive cannabinoids that have raised increasing interest in recent years. These compounds exhibit good tolerability and low toxicity, representing promising candidates for drug repositioning. To identify novel potential therapeutic targets f...
Bewaard in:
| Gepubliceerd in: | Molecules |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6680637/ https://ncbi.nlm.nih.gov/pubmed/31311157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules24142567 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|